This report provides a comprehensive analysis of CSL Limited's marketing strategies and their integration with sustainability practices. It begins with an introduction to CSL, its product offerings (plasma-derived therapies, vaccines, antivenoms, diagnostics, and pharmaceuticals), and its target customers (doctors, patients, medical shops, and hospitals). The report then explores the relationship between product characteristics, branding, packaging, labeling, and support services with sustainability. It delves into CSL's pricing strategies, including cost-plus, market-based, and premium pricing, examining how these are applied to various product lines. The report further investigates CSL's promotional activities (personal selling, advertising, public relations, point of display, and online marketing) and their impact on sustainability. It highlights CSL's efforts towards social, environmental, and economic benefits, emphasizing their commitment to supply chain security and sustainable distribution. Finally, the report compares CSL's marketing mix with those of Cipla and Pfizer, offering recommendations based on the analysis.